U.S. flag

An official website of the United States government

NM_002024.6(FMR1):c.990+14C>T AND Fragile X syndrome

Germline classification:
Benign (1 submission)
Last evaluated:
Apr 12, 2018
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001826716.1

Allele description [Variation Report for NM_002024.6(FMR1):c.990+14C>T]

NM_002024.6(FMR1):c.990+14C>T

Gene:
FMR1:fragile X messenger ribonucleoprotein 1 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
Xq27.3
Genomic location:
Preferred name:
NM_002024.6(FMR1):c.990+14C>T
HGVS:
  • NC_000023.11:g.147936627C>T
  • NG_007529.2:g.29637C>T
  • NM_001185075.2:c.990+14C>T
  • NM_001185076.2:c.990+14C>T
  • NM_001185081.2:c.990+14C>T
  • NM_001185082.2:c.990+14C>T
  • NM_002024.6:c.990+14C>TMANE SELECT
  • LRG_762t1:c.990+14C>T
  • LRG_762:g.29637C>T
  • NC_000023.10:g.147018146C>T
  • NM_002024.5:c.990+14C>T
Links:
dbSNP: rs25714
NCBI 1000 Genomes Browser:
rs25714
Molecular consequence:
  • NM_001185075.2:c.990+14C>T - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001185076.2:c.990+14C>T - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001185081.2:c.990+14C>T - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001185082.2:c.990+14C>T - intron variant - [Sequence Ontology: SO:0001627]
  • NM_002024.6:c.990+14C>T - intron variant - [Sequence Ontology: SO:0001627]

Condition(s)

Name:
Fragile X syndrome
Synonyms:
MENTAL RETARDATION, X-LINKED, ASSOCIATED WITH marXq28; Marker X syndrome; Martin-Bell syndrome; See all synonyms [MedGen]
Identifiers:
MONDO: MONDO:0010383; MedGen: C0016667; Orphanet: 449291; Orphanet: 908; OMIM: 300624

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV002082234Natera, Inc.
no assertion criteria provided
Benign
(Apr 12, 2018)
germlineclinical testing

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Details of each submission

From Natera, Inc., SCV002082234.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024